A Combined MRI Biomarker Approach Using a Non-Standard Multiple Factor Analysis

@article{Rebbah2018ACM,
  title={A Combined MRI Biomarker Approach Using a Non-Standard Multiple Factor Analysis},
  author={Sana Rebbah and Daniel Delahaye and St{\'e}phane Puechmorel and Florence Nicol and Pierre Mar{\'e}chal and Isabelle Berry},
  journal={2018 11th International Congress on Image and Signal Processing, BioMedical Engineering and Informatics (CISP-BMEI)},
  year={2018},
  pages={1-6}
}
In medical applications, various MRI biomarkers, which are extracted from different MRI modalities, are used to detect physiologic abnormalities but different biomarkers are usually sensitive to different aspects of the disease. Thus, it would be interesting to use the information carried by multiple biomarkers, especially in the context of clinical trials where the efficiency of a treatment should be judged as precisely as possible. This paper proposes an approach that combined various MRI… CONTINUE READING

Figures, Tables, and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

and J

F. Husson, J. Josse
  • Pags, Principal component methodshierarchical clustering-partitional clustering : why would we need to choose for visualizing data ?
  • 2010
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

MD1003 in progressive multiple sclerosis: 24-month brain MRI results of the MS-SPI trial, presented at the 7th Joint ECTRIMS - ACTRIMS Meeting, Paris, 26-Oct-2017

D. Arnold
  • 2017
VIEW 1 EXCERPT

Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis

L. Peyro Saint Paul, D. Debruyne, D. Bernard, D. M. Mock, G. L. Defer
  • Expert Opin Drug Metab Toxicol,
  • 2016
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…